CIK 0000275053 · Accelerated filer<br>Smaller reporting company
NATURES SUNSHINE PRODUCTS INC
Sign in to watch- Ticker
- NATR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- UT
- Entity type
- operating
- EIN
- 870327982
- Phone
- (801) 341-7900
- Business address
- 2901 WEST BLUEGRASS BLVD., SUITE 100, LEHI, UT, 84048
- Open-market buys, last 90 days
- $3,143,611
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$3,143,611. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-11 | Jones Leslie Shane EVP & Chief Financial Officer | Shares withheld for taxes | −2,343 | $14.50 | $34K | 106,344 |
| 2025-03-11 | Lanoy Jonathan David SVP, Chief Accounting Officer | Shares withheld for taxes | −833 | $14.50 | $12K | 55,392 |
| 2025-03-10 | Fuller Kevin Gregory Global Chief Marketing Officer | Grant or award | +13,148 | $14.74 | $194K | 24,218 |
| 2025-03-10 | Yates Bryant J EVP & President, Europe | Grant or award | +12,810 | $14.74 | $189K | 110,109 |
| 2025-03-10 | Comstock Tracee VP, Human Resources | Grant or award | +8,890 | $14.74 | $131K | 66,518 |
| 2025-03-10 | Norman Daniel C EVP & President, Asia | Grant or award | +16,651 | $14.74 | $245K | 75,827 |
| 2025-03-10 | Gonzalez Martin A. EVP, Global Supply Chain | Grant or award | +13,758 | $14.74 | $203K | 70,589 |
| 2025-03-10 | Moorehead Terrence Chief Executive Officer | Grant or award | +49,389 | $14.74 | $728K | 558,774 |
| 2025-03-10 | Herbert Kevin R. EVP & President, North America | Grant or award | +11,760 | $14.74 | $173K | 43,595 |
| 2025-03-10 | Brower Nathan G EVP, General Counsel | Grant or award | +11,966 | $14.74 | $176K | 60,755 |
| 2025-03-10 | Jones Leslie Shane EVP & Chief Financial Officer | Grant or award | +19,474 | $14.74 | $287K | 108,687 |
| 2025-03-10 | Lanoy Jonathan David SVP, Chief Accounting Officer | Grant or award | +8,882 | $14.74 | $131K | 56,225 |
| 2025-02-04 | May Katie Director | Grant or award | +1,766 | $14.16 | $25K | 1,766 |
| 2024-12-19 | Jones Leslie Shane EVP & Chief Financial Officer | Grant or award | −9,925 | $15.13 | $150K | 89,213 |
| 2024-11-27 | Norman Daniel C EVP & President, Asia | Gift | −3,600 | $16.44 | $59K | 59,176 |
| 2024-11-11 | Fasching Steven J. Director | Grant or award | +2,869 | $17.43 | $50K | 2,869 |
| 2024-10-15 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 10% owner | Sale | −2,300 | $13.02 | $30K | 64,167 |
| 2024-10-14 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 10% owner | Sale | −1,300 | $13.12 | $17K | 66,467 |
| 2024-10-11 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 10% owner | Sale | −1,580 | $13.37 | $21K | 67,767 |
| 2024-10-10 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 10% owner | Sale | −3,000 | $13.39 | $40K | 69,347 |
Page 12 of 92 · 1,829 trades